Showing results (1261-1270 of 3,978) with videos related to
Sort By:
Pageof 398
European Journal of Heart Failure|August 11, 2000
Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal studyA F Lee, R J MacFadyen, A D StruthersEuropean Journal of Heart Failure|August 11, 2000
Novel approaches to retard ventricular remodeling in heart failureF G SpinaleEuropean Journal of Heart Failure|August 11, 2000
Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1M C Petrie, S J McClure, M P Love, et al.European Journal of Heart Failure|August 11, 2000
Relation of atrial natriuretic peptides to left ventricular systolic and diastolic function in heart failureA A Wijbenga, A H Balk, F A Jonkman, et al.European Journal of Heart Failure|August 11, 2000
Plasma brain natriuretic peptide--an independent predictor of cardiovascular mortality in acute heart failureC M Yu, J E SandersonEuropean Journal of Heart Failure|August 11, 2000
Beta-blocker therapy in advanced heart failure: clinical characteristics and long-term outcomesC M O'Connor, W A Gattis, F Zannad, et al.European Journal of Heart Failure|August 11, 2000
Achieving appropriate endpoints in heart failure trials: the PRIME-II protocol. The Second Perspective Randomised study of Ibopamine on Mortality and EfficacyJ R Hampton, D J Van Veldhuisen, A J Cowley, et al.European Journal of Heart Failure|August 12, 2000
Does in-patient ECG monitoring have an impact on medical care in chronic heart failure patients?C Opasich, S Capomolla, P G Riccardi, et al.European Journal of Heart Failure|August 12, 2000
Screening, endpoint classification, and safety monitoring in the Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)B FagerbergEuropean Journal of Heart Failure|April 1, 2000
Celiprolol augments the effect of physical exercise on insulin sensitivity and serum lipid levels in chronic heart failureM Pietilä, K Malminiemi, R Huupponen, et al.Pageof 398